Dupixent and lymphoma (CTCL)

MDL 3180, D.N.J.

Filings

Coordinated

Bellwethers

Settlement

Wind-down

Cases are centralized before one judge for pretrial work.

Stage: Coordinated (MDL or JCCP)
Campaign window: Open
Coordination: MDL 3180
Court: D.N.J.
Category: Drugs

Updated Oct 23, 2026. Maintained by Jacob Malherbe.

New federal cases per week

2 new cases in the last 7 days. New dockets in D.N.J. naming the defendants, from CourtListener's public federal docket index. The outlined bar is the current week so far.

Jacob Score: 30

Litigation strength from 0 to 100. Last reviewed Jul 20, 2026. How it's set

Science
Momentum
Campaign
Timeline
Verdicts

What changed

Oct 23, 2026
New study
Lymphomatoid Papulosis-Like Lymphoid Reaction During Dupilumab Therapy for Atopic Dermatitis
International journal of dermatology. Paolino G et al.
PubMed (Int J Dermatol)
Jun 4, 2026
Case event
The JPML created MDL No. 3180 in the District of New Jersey before Judge Zahid N. Quraishi, with 15 transferred actions and 7 potential tag-along cases.
tavrn.ai
Feb 13, 2026
Case event
Plaintiffs in 15 cases across 12 federal courts asked the JPML to combine lawsuits alleging Dupixent caused or sped up cutaneous T-cell lymphoma (CTCL) and that Regeneron and Sanofi failed to warn.
verusllc.com
Oct 1, 2025
Case event
The first-filed Dupixent lymphoma case, a wrongful death claim (Richardson v. Regeneron), was filed in the Middle District of Tennessee.
tavrn.ai

Watch this tort

Get Dupixent developments at the top of the Monday briefing.

Related torts

Depo-Provera and meningioma Coordinated (MDL or JCCP), 61 new cases in 7 days
Ozempic and GLP-1 stomach injuries Coordinated (MDL or JCCP), 35 new cases in 7 days
Suboxone and tooth decay Coordinated (MDL or JCCP), 2 new cases in 7 days
GLP-1 drugs and vision loss (NAION) Coordinated (MDL or JCCP)

Advertising on Dupixent?

Mass Tort Ad Agency runs Meta tort campaigns for plaintiff firms and can show you what this tort's audience looks like.

Talk to Mass Tort Ad Agency